Join ACCP

 
Grants & Funding Opportunities

As part of ACCP's ongoing commitment to Members, we will routinely post appropriately aligned Grants & Funding Opportunities from a variety of sources. Information will be updated in a timely manner and we encourage Members to visit this link frequently for up-to-date information on valuable funding sources. Members are welcome to recommend additional links for posting by forwarding the information to Info@ACCP1.org.

Howard Hughes Medical Institute Accepting Applications for Medical Research Fellowships

The program is designed to give students the opportunity to immerse themselves in a year of basic, translational, or applied biomedical research. HHMI Medical Fellows become part of a community of Medical Fellows through regional meetings and other events; gain insight into a wide range of research areas and receive career advice from program alumni and other prominent physician-scientists; interact with HHMI investigators at an HHMI science meeting and learn about their latest findings; share their research and network with other trainees and renowned biomedical investigators at two Medical Fellows conferences during the year; participate in scientific conferences in their field and present their work; and spend a year evaluating whether research should be part of their career.

Students may select a mentor at any academic or nonprofit research institution in the United States (excluding the National Institutes of Health or any other federal agency) or abroad, provided the proposed mentor is affiliated with a U.S. fellowship institution, and then work with the mentor to develop a research proposal. Mentor selection and the research project proposal are key components of the application. Working with an HHMI investigator, early career scientist, or HHMI professor is encouraged but not required.

Medical, dental, and veterinary students at schools located in the United States are eligible for the program.

Visit the HHMI website for complete application guidelines.

ALS Association Issues RFP for Phase II Clinical Development of Novel Treatments

The ALS Association has announced a Request for Proposals for phase II clinical trials for novel, high-potential treatments for amyotrophic lateral sclerosis, also known as Lou Gehrig’s disease.

The goal of this RFP is to expedite the process of bringing new treatments forward for testing in people with ALS and to measure whether a therapeutic agent is reaching its target. In the United States, ALS affects one in approximately 30,000 people, with 5,000 new diagnoses each year. There is currently one FDA-approved treatment for ALS, Riluzole (Rilutek), which was introduced in the early 1990s.

Grants of up to $1.5 million will be awarded for phase II clinical trials that include therapeutic interventions that have a pharmacodynamics marker that can measure whether the pathway of interest has been affected as well as a plan to collect samples for biomarker studies.

The program is open to academic-industry partnerships, including pharmaceutical, biotherapeutic/biotechnology companies, academic members of the NEALS Consortium, and ALS scientists around the world. Funding will cover direct costs only.

Deadline Letters of Intent Jan 9, 2015

Clinical Studies of Safety and Effectiveness of Orphan Products Research Project Grant (R01)

The application due dates are February 4, 2015; February 3, 2016; February 1, 2017; and February 7, 2018

The Food and Drug Administration (FDA) is announcing the availability of grant funds for the support of FDA's Office of Orphan Products Development grant program. The goal of FDA's Orphan Products Development (OPD) grant program is to support the clinical development of products for use in rare diseases or conditions where no current therapy exists or where the proposed product will be superior to the existing therapy. FDA provides grants for clinical studies on safety and/or effectiveness that will either result in, or substantially contribute to, market approval of these products. Applicants must include in the application's Background and Significance section documentation to support the assertion that the product to be studied meets the statutory criteria to qualify for the grant and an explanation of how the proposed study will either help support product approval or provide essential data needed for product development.

Grant funding opportunities at the National Institutes of Health can be found at http://grants.nih.gov/grants/guide/. To Subscribe to the NIH Guide LISTSERV, send an e-mail to listserv@list.nih.gov with the following text in the message body (not the "Subject" line):
subscribe NIHTOC-L your name
(Example: subscribe NIHTOC-L Bill Jones)

Your e-mail address will be automatically obtained from the e-mail message and add you to the LISTSERV.

Grant opportunities from the Substance Abuse and Mental Health Administration:
http://www.samhsa.gov/samhsa_news/volumexvi_1/article5.htm

www.Grants.gov provides information on funding opportunities across all US Federal agencies:

Grant opportunities from the Alzheimer's Drug Discovery Foundation:
http://www.alzdiscovery.org/index.php/research-programs/grant-opportunities

CenterWatch offers several easy-to-search resources on drugs in various stages of development and approval:
http://www.centerwatch.com/drug-information/



21750 Red Rum Drive, Suite 137, Ashburn, VA  20147    Mailing address: PO Box 1758, Ashburn, VA  20146
571-291-3493     Fax: 571-918-4167     Contact Us
Home     About ACCP     Member Login     Healthcare Professionals
Continuing Education     Meetings     Publications     Public Policy     Student Outreach

Site Map | Site contents © 2014 ACCP